Literature DB >> 35231177

Current Developments and Challenges of mRNA Vaccines.

Jinjin Chen1, Jianzhu Chen2, Qiaobing Xu1.   

Abstract

mRNA vaccines have brought about a great revolution in the vaccine fields owing to their simplicity and adaptability in antigen design, potential to induce both humoral and cell-mediated immune responses and demonstrated high efficacy, and rapid and low-cost production by using the same manufacturing platform for different mRNA vaccines. Multiple mRNA vaccines have been investigated for both infectious diseases and cancers, showing significant superiority to other types of vaccines. Although great success of mRNA vaccines has been achieved in the control of the coronavirus disease 2019 pandemic, there are still multiple challenges for the future development of mRNA vaccines. In this review, the most recent developments of mRNA vaccines against both infectious diseases and cancers are summarized for an overview of this field. Moreover, the challenges are also discussed on the basis of these developments.

Entities:  

Keywords:  LNP; cancer vaccines; infectious diseases; lipid nanoparticle; mRNA vaccines; self-adjuvanting effect

Mesh:

Substances:

Year:  2022        PMID: 35231177     DOI: 10.1146/annurev-bioeng-110220-031722

Source DB:  PubMed          Journal:  Annu Rev Biomed Eng        ISSN: 1523-9829            Impact factor:   9.590


  4 in total

1.  Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response.

Authors:  Jinjin Chen; Zhongfeng Ye; Changfeng Huang; Min Qiu; Donghui Song; Yamin Li; Qiaobing Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-15       Impact factor: 12.779

2.  Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development.

Authors:  Shuhang Wang; Yuqi Yang; Lu Li; Peiwen Ma; Yale Jiang; Minghui Ge; Yue Yu; Huiyao Huang; Yuan Fang; Ning Jiang; Huilei Miao; Hao Guo; Linlin Yan; Yong Ren; Lichao Sun; Yan Zha; Ning Li
Journal:  Vaccines (Basel)       Date:  2022-07-22

Review 3.  mRNA vaccines in the prevention and treatment of diseases.

Authors:  Yangzhuo Gu; Jiangyao Duan; Na Yang; Yuxin Yang; Xing Zhao
Journal:  MedComm (2020)       Date:  2022-08-25

4.  Nanocarriers for cancer nano-immunotherapy.

Authors:  Isra Rana; Jaeeun Oh; Juwon Baig; Jeong Hyun Moon; Sejin Son; Jutaek Nam
Journal:  Drug Deliv Transl Res       Date:  2022-10-03       Impact factor: 5.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.